Mettler-Toledo [MTD] vs Idexx Laboratories [IDXX] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Mettler-Toledo International Inc. wins in 10 metrics, Idexx Laboratories, Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Mettler-Toledo International Inc. | Idexx Laboratories, Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.07 | 42.92 | Mettler-Toledo International Inc. |
| Price-to-Book Ratio | -1,090.80 | 27.85 | Idexx Laboratories, Inc. |
| Debt-to-Equity Ratio | -95.84 | 60.83 | Idexx Laboratories, Inc. |
| PEG Ratio | 1.79 | 2.41 | Mettler-Toledo International Inc. |
| EV/EBITDA | 23.02 | 31.12 | Mettler-Toledo International Inc. |
| Profit Margin (TTM) | 21.59% | 24.62% | Idexx Laboratories, Inc. |
| Operating Margin (TTM) | 30.71% | 29.76% | Mettler-Toledo International Inc. |
| EBITDA Margin (TTM) | 30.71% | 29.76% | Mettler-Toledo International Inc. |
| Return on Equity | -3,677.41% | 66.20% | Idexx Laboratories, Inc. |
| Return on Assets (TTM) | 20.35% | 25.59% | Idexx Laboratories, Inc. |
| Free Cash Flow (TTM) | $848.65M | $1.04B | Idexx Laboratories, Inc. |
| 1-Year Return | 2.17% | 9.77% | Idexx Laboratories, Inc. |
| Price-to-Sales Ratio (TTM) | 6.36 | 10.38 | Mettler-Toledo International Inc. |
| Enterprise Value | $27.90B | $46.85B | Idexx Laboratories, Inc. |
| EV/Revenue Ratio | 6.93 | 10.89 | Mettler-Toledo International Inc. |
| Gross Profit Margin (TTM) | 59.79% | 60.35% | Idexx Laboratories, Inc. |
| Revenue per Share (TTM) | $195 | $54 | Mettler-Toledo International Inc. |
| Earnings per Share (Diluted) | $42.05 | $13.07 | Mettler-Toledo International Inc. |
| Beta (Stock Volatility) | 1.44 | 1.72 | Mettler-Toledo International Inc. |
| Short % of Float | 3.44% | 2.74% | Idexx Laboratories, Inc. |
Mettler-Toledo International Inc. vs Idexx Laboratories, Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mettler-Toledo International Inc. | 0.95% | 1.46% | -6.35% | -8.25% | -17.03% | -16.36% |
| Idexx Laboratories, Inc. | 0.72% | -0.58% | 0.29% | -12.94% | -21.29% | -15.71% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mettler-Toledo International Inc. | 2.17% | -11.41% | -6.07% | 215.58% | 642.64% | 1,746.10% |
| Idexx Laboratories, Inc. | 9.77% | 19.69% | 0.93% | 539.65% | 1,408.78% | 2,730.39% |
Performance & Financial Health Analysis: Mettler-Toledo International Inc. vs Idexx Laboratories, Inc.
| Metric | MTD | IDXX |
|---|---|---|
| Market Information | ||
| Market Cap | $25.60B | $44.66B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 135,040 | 480,502 |
| 90 Day Avg. Volume | 153,497 | 516,114 |
| Last Close | $1,180.48 | $564.74 |
| 52 Week Range | $1,023.05 - $1,525.17 | $506.91 - $769.98 |
| % from 52W High | -22.60% | -26.66% |
| All-Time High | $1,714.75 (Dec 27, 2021) | $769.98 (Nov 26, 2025) |
| % from All-Time High | -31.16% | -26.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.14% |
| Quarterly Earnings Growth | 0.13% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.22% | 0.25% |
| Operating Margin (TTM) | 0.31% | 0.30% |
| Return on Equity (TTM) | -36.77% | 0.66% |
| Debt to Equity (MRQ) | -95.84 | 60.83 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-1.16 | $20.14 |
| Cash per Share (MRQ) | $3.29 | $2.26 |
| Operating Cash Flow (TTM) | $955.77M | $1.18B |
| Levered Free Cash Flow (TTM) | $687.08M | $790.74M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Mettler-Toledo International Inc. vs Idexx Laboratories, Inc.
| Metric | MTD (Apr 24, 2026) | IDXX (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.07 | 42.92 |
| Forward P/E | 24.70 | 34.19 |
| PEG Ratio | 1.79 | 2.41 |
| Price to Sales (TTM) | 6.36 | 10.38 |
| Price to Book (MRQ) | -1,090.80 | 27.85 |
| Market Capitalization | ||
| Market Capitalization | $25.60B | $44.66B |
| Enterprise Value | $27.90B | $46.85B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.93 | 10.89 |
| Enterprise to EBITDA | 23.02 | 31.12 |
| Risk & Other Metrics | ||
| Beta | 1.44 | 1.72 |
| Book Value per Share (MRQ) | $-1.16 | $20.14 |
Financial Statements Comparison: Mettler-Toledo International Inc. vs Idexx Laboratories, Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MTD (2025) | IDXX (2025) |
|---|---|---|
| Revenue/Sales | 4.03B | 4.30B |
| Cost of Goods Sold | 1.64B | 1.64B |
| COGS % of Revenue | 40.6% | 38.2% |
| Gross Profit | 2.39B | 2.66B |
| Gross Margin | 59.4% | 61.8% |
| Research & Development | 199.37M | 251.21M |
| Operating Income (EBIT) | 1.12B | 1.36B |
| Operating Margin | 27.8% | 31.6% |
| EBITDA | 1.26B | 1.51B |
| EBITDA Margin | 31.3% | 35.0% |
| Pre-Tax Income | 1.05B | 1.32B |
| Pre-Tax Income % of Revenue | 26.1% | 30.8% |
| Income Tax | 179.72M | 264.73M |
| Income Tax % of Revenue | 4.5% | 6.2% |
| Net Income (Profit) | 869.19M | 1.06B |
| Profit Margin | 21.6% | 24.6% |
Balance Sheet & Liquidity Metrics
| Metric | MTD (2025) | IDXX (2025) |
|---|---|---|
| Cash & Equivalents | 66.89M | 180.07M |
| Total Current Assets | 1.36B | 1.41B |
| Total Current Assets % of Revenue | 33.8% | 32.9% |
| Total Current Liabilities | 1.20B | 1.15B |
| Total Current Liabilities % of Revenue | 29.8% | 26.7% |
| Long-Term Debt | 2.09B | 475.99M |
| Long-Term Debt % of Revenue | 51.9% | 11.1% |
| Total Shareholders Equity | -23.64M | 1.61B |
| Retained Earnings | 9.24B | 6.39B |
| Retained Earnings % of Revenue | 229.4% | 148.5% |
| Property, Plant & Equipment | 0 | 123.23M |
Cash Flow Statement Comparison
| Metric | MTD (2025) | IDXX (2025) |
|---|---|---|
| Operating Cash Flow | 990.02M | 1.17B |
| Operating Cash Flow % of Revenue | 24.6% | 27.3% |
| Capital Expenditures | -107.12M | -124.68M |
| Free Cash Flow | 848.65M | 1.04B |
| FCF Margin | 21.1% | 24.2% |
| Debt Repayment | -1.97B | -428.39M |
| Common Stock Repurchase | -800.00M | -1.22B |
Short Interest & Institutional Ownership Analysis
| Metric | MTD | IDXX |
|---|---|---|
| Shares Short | 607,385 | 1.91M |
| Short Ratio | 3.29 | 3.85 |
| Short % of Float | 3.44% | 2.74% |
| Shares Outstanding | 20.36M | 79.71M |
| Float Shares | 20.22M | 78.75M |
| % Held by Insiders | 0.43% | 0.71% |
| % Held by Institutions | 102.91% | 96.04% |
| % Held by Public | -3.34% | 3.25% |
Dividend Analysis & Yield Comparison: Mettler-Toledo International Inc. vs Idexx Laboratories, Inc.
| Metric | MTD | IDXX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |